The five-year survival rate for pancreatic cancer hoovers at just 9%, underscoring the need for advances to cure this deadly form of cancer.
Researchers at Tel Aviv Univerity's Sackler Faculty of Medicine and the Cancer Research Center at Sheba Medical Center have developed a molecule they think can eradicate cancer cells.
In a recent research paper that was published in the journal Oncotarget, Prof. Malka Cohen-Armon of Tel Aviv University and Dr. Talia Golan of Sheba Medical Center explained how by injecting the PJ34 molecule in xenografts, it caused a "substantial eradication" of pancreas cancer cells.
The change in the tumor sized began to shrink after three weeks of daily injections of PJ34. The tumor disappeared completely on day 56.
Thirty-days after the treatment with the PJ34 injections ended, there was an 80% to 90% reduction in the number of cancer cells in the mouse's tumor. The mice didn't have any side-effects because of the treatment. It also didn't impact their weight or how they acted.
To read more, click here.